跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
得菲尔 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Paracetamol and Amantadine Hydrochloride Tablets
Approved
化学药品
Compound Paracetamol and Amantadine Hydrochloride Tablets
葵花药业集团佳木斯鹿灵制药有限公司
🇨🇳 National Medical Products Administration
Approval Date
Jul 28, 2020
Approval ID
7Leaf8y3Yh5
Company
葵花药业集团佳木斯鹿灵制药有限公司
Type
化学药品
Approval Details
Approval Id
7Leaf8y3Yh5
Approval Number
国药准字H23023403
Generic Name
复方氨酚烷胺片
Generic Name En
Compound Paracetamol and Amantadine Hydrochloride Tablets
Brand Name
得菲尔
Drug Type
化学药品
Dosage Form
片剂(素片)
Strength
复方
Reg Date
2020-07-28
Company Name
葵花药业集团佳木斯鹿灵制药有限公司
Company Address
佳木斯市东风区乌苏里江街91号
Production Company Name
葵花药业集团佳木斯鹿灵制药有限公司
Production Company Address
佳木斯市东风区乌苏里江街91号
Company Detail Path
/organization/kui-hua-yao-ye-ji-tuan-jia-mu-si-lu-ling-zhi-yao-you-xian-gong-si
Production Company Detail Path
/organization/kui-hua-yao-ye-ji-tuan-jia-mu-si-lu-ling-zhi-yao-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 28, 2020
Approval ID
7Leaf8y3Yh5
Type
化学药品
Back to NMPA Approvals
